Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms.

Shedlock DJ, Bailey MA, Popernack PM, Cunningham JM, Burton DR, Sullivan NJ.

Virology. 2010 Jun 5;401(2):228-35. doi: 10.1016/j.virol.2010.02.029. Epub 2010 Mar 20.

2.

Structural and molecular basis for Ebola virus neutralization by protective human antibodies.

Misasi J, Gilman MS, Kanekiyo M, Gui M, Cagigi A, Mulangu S, Corti D, Ledgerwood JE, Lanzavecchia A, Cunningham J, Muyembe-Tamfun JJ, Baxa U, Graham BS, Xiang Y, Sullivan NJ, McLellan JS.

Science. 2016 Mar 18;351(6279):1343-6. doi: 10.1126/science.aad6117. Epub 2016 Feb 25.

3.

Structural basis for differential neutralization of ebolaviruses.

Bale S, Dias JM, Fusco ML, Hashiguchi T, Wong AC, Liu T, Keuhne AI, Li S, Woods VL Jr, Chandran K, Dye JM, Saphire EO.

Viruses. 2012 Apr;4(4):447-70. doi: 10.3390/v4040447. Epub 2012 Apr 5. Review.

4.

Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.

Keck ZY, Enterlein SG, Howell KA, Vu H, Shulenin S, Warfield KL, Froude JW, Araghi N, Douglas R, Biggins J, Lear-Rooney CM, Wirchnianski AS, Lau P, Wang Y, Herbert AS, Dye JM, Glass PJ, Holtsberg FW, Foung SK, Aman MJ.

J Virol. 2015 Oct 14;90(1):279-91. doi: 10.1128/JVI.02172-15. Print 2016 Jan 1.

5.

Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein.

Koellhoffer JF, Chen G, Sandesara RG, Bale S, Saphire EO, Chandran K, Sidhu SS, Lai JR.

Chembiochem. 2012 Nov 26;13(17):2549-57. doi: 10.1002/cbic.201200493. Epub 2012 Oct 30.

6.

Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP.

Reynard O, Volchkov VE.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S372-8. doi: 10.1093/infdis/jiv303. Epub 2015 Aug 1.

PMID:
26232760
7.

Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.

Bornholdt ZA, Ndungo E, Fusco ML, Bale S, Flyak AI, Crowe JE Jr, Chandran K, Saphire EO.

MBio. 2016 Feb 23;7(1):e02154-15. doi: 10.1128/mBio.02154-15.

8.

Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).

Sobarzo A, Groseth A, Dolnik O, Becker S, Lutwama JJ, Perelman E, Yavelsky V, Muhammad M, Kuehne AI, Marks RS, Dye JM, Lobel L.

J Infect Dis. 2013 Jul 15;208(2):299-309. doi: 10.1093/infdis/jit162. Epub 2013 Apr 12.

PMID:
23585686
9.

Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.

Qiu X, Alimonti JB, Melito PL, Fernando L, Ströher U, Jones SM.

Clin Immunol. 2011 Nov;141(2):218-27. doi: 10.1016/j.clim.2011.08.008. Epub 2011 Aug 31.

PMID:
21925951
10.

Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.

Fong RH, Banik SS, Mattia K, Barnes T, Tucker D, Liss N, Lu K, Selvarajah S, Srinivasan S, Mabila M, Miller A, Muench MO, Michault A, Rucker JB, Paes C, Simmons G, Kahle KM, Doranz BJ.

J Virol. 2014 Dec;88(24):14364-79. doi: 10.1128/JVI.01943-14. Epub 2014 Oct 1.

11.

Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.

Ilinykh PA, Shen X, Flyak AI, Kuzmina N, Ksiazek TG, Crowe JE Jr., Bukreyev A.

J Virol. 2016 Mar 28;90(8):3890-3901. doi: 10.1128/JVI.00101-16. Print 2016 Apr.

12.

Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.

Holtsberg FW, Shulenin S, Vu H, Howell KA, Patel SJ, Gunn B, Karim M, Lai JR, Frei JC, Nyakatura EK, Zeitlin L, Douglas R, Fusco ML, Froude JW, Saphire EO, Herbert AS, Wirchnianski AS, Lear-Rooney CM, Alter G, Dye JM, Glass PJ, Warfield KL, Aman MJ.

J Virol. 2015 Oct 14;90(1):266-78. doi: 10.1128/JVI.02171-15. Print 2016 Jan 1.

13.

Epitopes involved in antibody-mediated protection from Ebola virus.

Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK.

Science. 2000 Mar 3;287(5458):1664-6.

14.

The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.

Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE Jr.

MBio. 2013 Nov 19;4(6):e00873-13. doi: 10.1128/mBio.00873-13.

15.

Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus.

Audet J, Wong G, Wang H, Lu G, Gao GF, Kobinger G, Qiu X.

Sci Rep. 2014 Nov 6;4:6881. doi: 10.1038/srep06881.

16.

Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines.

Dowling W, Thompson E, Badger C, Mellquist JL, Garrison AR, Smith JM, Paragas J, Hogan RJ, Schmaljohn C.

J Virol. 2007 Feb;81(4):1821-37. Epub 2006 Dec 6.

17.

Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein.

Zhong L, Haynes L, Struble EB, Tamin A, Virata-Theimer ML, Zhang P.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):1056-60. doi: 10.1016/j.bbrc.2009.10.115. Epub 2009 Oct 25.

PMID:
19861118
18.

The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2.

Lennemann NJ, Walkner M, Berkebile AR, Patel N, Maury W.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S204-9. doi: 10.1093/infdis/jiv201. Epub 2015 Jun 2.

19.

Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it.

Lee JE, Saphire EO.

Curr Opin Struct Biol. 2009 Aug;19(4):408-17. doi: 10.1016/j.sbi.2009.05.004. Epub 2009 Jun 24. Review.

20.

A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.

Lam S, Nyo M, Phuektes P, Yew CW, Tan YJ, Chu JJ.

MAbs. 2015;7(6):1178-94. doi: 10.1080/19420862.2015.1083664. Epub 2015 Aug 25.

Supplemental Content

Support Center